Demo Data from EDBT 2026 / reviewers in the wild / expert
Carlo Di Bello
dblp:74/5650
· DBLP profile ↗
1ranked-venue papers
0as first author
0since 2021 · last 2003
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
cancer genomics |
0.0 | 1 | 2003 | PCA disjoint models for multiclass cancer analysis using gene expression data · Bioinform. 2003 |
Bioinformatics and computational biology › gene expression analysis
gene expression classification |
0.0 | 1 | 2003 | PCA disjoint models for multiclass cancer analysis using gene expression data · Bioinform. 2003 |
Bioinformatics and computational biology › functional genomics
marker gene identification |
0.0 | 1 | 2003 | PCA disjoint models for multiclass cancer analysis using gene expression data · Bioinform. 2003 |
Methods — techniques the papers use, named apart from their topics
principal component analysis · 0.0disjoint principal component models · 0.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2003 | PCA disjoint models for multiclass cancer analysis using gene expression dataabstractMOTIVATION: Microarray expression profiling appears particularly promising for a deeper understanding of cancer biology and to identify molecular signatures supporting the histological classification schemes of neoplastic specimens. However, molecular diagnostics based on microarray data presents major challenges due to the overwhelming number of variables and the complex, multiclass nature of tumor samples. Thus, the development of marker selection methods, that allow the identification of those genes that are most likely to confer high classification accuracy of multiple tumor types, and of multiclass classification schemes is of paramount importance. RESULTS: A computational procedure for marker identification and for classification of multiclass gene expression data through the application of disjoint principal component models is described. The identified features represent a rational and dimensionally reduced base for understanding the basic biology of diseases, defining targets for therapeutic intervention, and developing diagnostic tools for the identification and classification of multiple pathological states. The method has been tested on different microarray data sets obtained from various human tumor samples. The results demonstrate that this procedure allows the identification of specific phenotype markers and can classify previously unseen instances in the presence of multiple classes. Silvio Bicciato, Alessandra Luchini, Carlo Di Bello |
Bioinform. | 3 |